Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 12
Submit an article Journal homepage
457
Views
6
CrossRef citations to date
0
Altmetric
Oncology: Original Article

Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib

Beth SherrillRTI Health Solutions Research Triangle Park, NC, USACorrespondence[email protected]
,
Bintu SherifRTI Health Solutions Research Triangle Park, NC, USA
,
Mayur M. AmonkarGSK Oncology Collegeville, PA, USA
,
Julie MaltzmanGSK Oncology Collegeville, PA, USA
,
Lisa O’RourkeGSK Oncology Collegeville, PA, USA
&
Stephen JohnstonRoyal Marsden NHS Foundation Trust & Institute of Cancer Research London, UK
Pages 2245-2252 | Accepted 01 Sep 2011, Published online: 12 Oct 2011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.